NV-GGPOKER
8.9.2020 20:13:27 CEST | Business Wire | Press release
The international WSOP Online 2020 tournament series, played on GGPoker, concluded today. A number of long-standing poker records were smashed over the course of the 54 event series--including the largest prize pool ever for an online tournament.
Highlights of WSOP Online 2020 include:
● The largest online poker tournament ever : $27,559,500 in Event #77: WSOP Online $5K Main Event
● The biggest online poker tournament prize ever awarded : $3,904,685 to Stoyan Madanzhiev, winner of Event 77: WSOP Online $5K Main Event
● The most entries ever for a WSOP tournament : 44,576 in Event #71: BIG 50
● Total prizes paid across all 54 tournaments : $147,789,550 (average prize pool: $2,736,844)
● Total number of WSOP Online 2020 tournament entries : 239,754
● Number of nationalities represented across the entire WSOP Online player base : 166
● Amount raised for Caesars Cares charity : $354,756 ($257,853 raised by the worldwide poker community, $96,903 donated by GGPoker)
● Number of tournaments with a prize pool of at least $1,000,000 : 45
● Number of tournaments with a prize pool of at least $5,000,000 : 5
● Number of tournaments with a prize pool of at least $10,000,000 : 2
● Number of tournaments with more than 10,000 entries: 5
● Multiple event winners : Alex Stasiak (winner of Events #33 and 52)
● Multiple final tables played : 39 players made multiple final tables, with five players making three final tables each (Michael Watson, Paul Teoh, Ajay Chabra, Bruno Albuquerque and Connor Drinan)
● Female event winners: 3 (Kristen Bicknell - Event # 44, Thi Truong - Event #74 and Melika Razavi - Event #82)
● Number of players that cashed more than 10 times across all 54 events : 281
● Number of players that won at least $100,000 in cash : 203
The flagship World Series of Poker (WSOP) live poker tournament in Las Vegas was postponed due to the public health emergency and as a result, an online series of events took place at GGPoker from July 19 through September 6. In total, 54 WSOP bracelets were claimed in GGPoker’s WSOP Online 2020 series. The tournaments marked the first time that players located outside the U.S. were able to compete for official WSOP bracelets online.
“Obviously the events of 2020 have been unprecedented, and hosting the WSOP Online series at GGPoker wasn’t in our plans at the start of the year,” said Ty Stewart, Executive Director of the World Series of Poker. “But going online has been a wonderful experience, with tens of thousands of new players all over the world able to experience some of WSOP magic that they might have been otherwise unable to - we’re delighted that the series has been such a resounding success!”
The WSOP Online 2020 series was extensively covered in the media, with tournament action regularly broadcast on GGPoker.TV and Poker Central, and tournament reports published on PokerNews and elsewhere.
“For 50 years, the WSOP has been the gold standard in the industry,” said Steve Preiss, Head of Poker Operations at GGPoker. “By introducing features like SnapCam and day 2 staking, GGPoker’s entire team worked tirelessly to bring our players a fun, unique experience just like they’d expect at the live WSOP.”
The WSOP Online 2020 Main Event was won by Bulgarian-native Stoyan Madanzhiev, who claimed a record-setting $3.9M prize. Other event winners included GGPoker ambassador Fedor Holz and well-known poker players Juha Helppi, Roberto Romanello, Kristen Bicknell, Daniel Dvoress, Eoghan O’Dea, David Peters,Christian Rudolph. Notable players that participated in WSOP events included soccer superstar Neymar, former world champion boxers Riddick Bowe & Amir Khan, tennis legend Boris Becker, Australian cricket player Shane Warne, mixed martial artists Elias Theodorou & Patrick Côté and former elite soccer player Andriy Shevchenko.
“I’m personally very proud to be part of the effort that brought such a special WSOP series to the entire world,” said GGPoker ambassador, Daniel Negreanu. “The feedback has been overwhelmingly positive, and we even got to break a lot of poker records along the way!”
About GGPoker : GGPoker is one of the world’s leading online poker rooms, with a growing global player base. It offers a range of innovative games and features such as the patented Rush & Cash poker, All-In or Fold, Spin & Gold, integrated staking platform, SnapCam video messaging, the ability to squeeze your hole cards, PokerCraft, and Smart HUD, all designed to enhance gaming experiences and make poker more fun than ever.
Find out more about GGPoker at GGPoker.com and on Facebook and Twitter .
About the World Series of Poker
The World Series of Poker® is the largest, richest and most prestigious gaming event in the world, having awarded more than $3.29 billion in prize money and the prestigious gold bracelet, globally recognized as the sport’s top prize. Featuring a comprehensive slate of tournaments in every major poker variation, the WSOP is poker’s longest-running tournament in the world, dating back to 1970. In 2019, the event attracted 187,298 entrants from 118 different countries to the Rio All-Suite Hotel & Casino in Las Vegas and awarded more than $293 million in prize money. In addition, the WSOP has formed groundbreaking alliances in broadcasting, digital media and corporate sponsorships, while successfully expanding the brand internationally with the advent of WSOP Europe in 2007 and the WSOP Asia-Pacific in 2013 and the WSOP International Circuit Series in 2015. For more information on the WSOP, please visit www.wsop.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200908005911/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom